Europe recommends Tecentriq in bladder cancer, but efficacy doubts persistThe European Union’s CHMP committee recommended 11 medicines on Friday, including five orphan drugs. Among the most notable Share XEurope recommends Tecentriq in bladder cancer, but efficacy doubts persisthttps://pharmaphorum.com/news/europes-chmp-recommends-tecentriq-doubts-efficacy-persist/
